טוען...
The Effect of Aliskiren on Exercise Capacity in Older Patients with Heart Failure and Preserved Ejection Fraction: A Randomized, Placebo-Controlled, Double-Blind Trial
In older patients (70±7 years) with chronic well-compensated heart failure with preserved ejection and controlled blood pressure, 6 months treatment with aliskiren (direct renin inhibitor) showed non-significant trends for modest improvements in peak exercise oxygen consumption (14.9±0.2 ml/kg/min v...
שמור ב:
| הוצא לאור ב: | Am Heart J |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7707854/ https://ncbi.nlm.nih.gov/pubmed/29910050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2018.03.019 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|